BACKGROUND: It has been shown that the amount of healed bone following guided bone regeneration (GBR) with demineralized freeze-dried bone allograft (DFDBA) and a bioabsorbable membrane is significantly less than the initial quantity. A study was designed to determine if the amount of GBR would be affected by using an osteoinductive DFDBA and bioabsorbable membrane and membrane stabilization. METHODS: Eleven extraction sites (10 patients) were treated with DFDBA and bioabsorbable membrane before placing endosseous implants. Standardized alveolar height and width measurements were taken after extraction, GBR, and 4 months postoperatively, at predetermined measurement points (sites midpoint and 3 mm mesial and distal from the midpoint) and classified as augmented (<1 mm increase of GBR height or width) or grafted (>1 mm increase). Five membranes were stabilized. RESULTS: Three mm from the crest, augmented points exhibited a complete loss of augmented width. There was also some loss of pre-GBR bone width (ranging from 4.7% to 20%) at augmented and grafted points. Five mm from the crest, augmented points lost 83.3% to 92.3% of augmented width and grafted points lost 12.9% to 18% of pre-GBR width. Loss of augmented height ranged from 93.5% to 100%. Augmented (except distal) and grafted measurement points lost 2.1% to 12% of pre-GBR height. Comparing tacked and non-tacked sites, the former manifested less loss of augmented bone width, the latter augmented bone height. CONCLUSIONS: Results indicate a complete loss of augmented width 3 mm from the crest and almost complete loss in height and width 5 mm from the crest. Membrane stabilization appeared beneficial.
BACKGROUND: It has been shown that the amount of healed bone following guided bone regeneration (GBR) with demineralized freeze-dried bone allograft (DFDBA) and a bioabsorbable membrane is significantly less than the initial quantity. A study was designed to determine if the amount of GBR would be affected by using an osteoinductive DFDBA and bioabsorbable membrane and membrane stabilization. METHODS: Eleven extraction sites (10 patients) were treated with DFDBA and bioabsorbable membrane before placing endosseous implants. Standardized alveolar height and width measurements were taken after extraction, GBR, and 4 months postoperatively, at predetermined measurement points (sites midpoint and 3 mm mesial and distal from the midpoint) and classified as augmented (<1 mm increase of GBR height or width) or grafted (>1 mm increase). Five membranes were stabilized. RESULTS: Three mm from the crest, augmented points exhibited a complete loss of augmented width. There was also some loss of pre-GBR bone width (ranging from 4.7% to 20%) at augmented and grafted points. Five mm from the crest, augmented points lost 83.3% to 92.3% of augmented width and grafted points lost 12.9% to 18% of pre-GBR width. Loss of augmented height ranged from 93.5% to 100%. Augmented (except distal) and grafted measurement points lost 2.1% to 12% of pre-GBR height. Comparing tacked and non-tacked sites, the former manifested less loss of augmented bone width, the latter augmented bone height. CONCLUSIONS: Results indicate a complete loss of augmented width 3 mm from the crest and almost complete loss in height and width 5 mm from the crest. Membrane stabilization appeared beneficial.